Cite
MLA Citation
Ben J. Slotman et al.. “Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.” Lung cancer, vol. 108, 2017, pp. 150–153. http://access.bl.uk/ark:/81055/vdc_100047026459.0x000053